Canertinib is an irreversible pan-erbB tyrosine kinase inhibitor investigated for treating various cancers. It works by inhibiting growth factor receptor signaling pathways. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include canertinibum, Canertinib free base and DTXSID8048943. Its PubChem CID is 156414.
Canertinib
| CAS No | 267243-28-7 |
|---|---|
| Molecular Formula | C24H25ClFN5O3 |
| Molecular Weight | 485.94 g/mol |
| Synonyms | N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(dimethylamino)but-2-enamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Canertinib is an irreversible pan-erbB tyrosine kinase inhibitor investigated for treating various cancers. It works by inhibiting growth factor receptor signaling pathways.
The listed CAS number is 267243-28-7.
The listed molecular formula is C24H25ClFN5O3.
The listed molecular weight is 485.94 g/mol.
N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(dimethylamino)but-2-enamide.
The source lists canertinibum, Canertinib free base and DTXSID8048943.